FSR Pilot Grant supports clinician scientists conducting small-scale sarcoidosis research to advance patient-centered outcomes, identify biomarkers, improve diagnosis, and strengthen care.
Funder: Foundation for Sarcoidosis Research
Due Dates (Anticipated): June 2027 (Letter of Intent) | September 2027 (Full proposal, invitation only)
Funding Amounts: $100,000 per project over two years, including up to 10% indirect costs
Summary: Supports new or existing small-scale sarcoidosis research advancing patient-centered outcomes, biomarkers, diagnosis, and care.
Key Information: Full proposals require an invitation, and awards must be administered by an eligible affiliated institution.
The Foundation for Sarcoidosis Research (FSR) Pilot Grant supports smaller-scale or pilot research projects focused on sarcoidosis. Established in 2018, the program accepts new or existing projects that may be funded solely by FSR or in partnership with additional funders. Clinician scientists from any discipline are invited to propose work addressing the disease.
Projects must align with one or more priorities in FSR’s Research Agenda: standardizing patient-centered outcomes, identifying biomarkers for prognosis or progression, improving diagnosis, strengthening the consistency and quality of care, or identifying biomarkers for treatment monitoring. Supported approaches may include validating patient-reported outcomes, developing diagnostic tools, identifying predictive molecular signatures, or creating evidence-based care protocols. FSR also emphasizes rigorous methods, health equity, real-world evidence, patient perspectives, investigator development, and collaboration with existing research efforts.